Zealand Pharma – Notice of Interim Report for First Nine Months of 2012 (Unaudited) and Conference Call

Published: Nov 09, 2012

Copenhagen, [9] November 2012 – Zealand Pharma A/S (NASDAQ OMX Copenhagen: ZEAL), a Danish biotechnology company dedicated to the discovery and development of novel peptide drugs, will announce its Interim Report for the first nine months of 2012 on Tuesday, 13 November 2012.

Back to news